COVID-19: Vaccines and Therapeutics
Leaders from Henry Ford Health System and the Islamic Center of America discuss their collaboration to increase vaccinations in the Muslim community around Detroit, and the cultural and logistical factors they considered to make their effort successful.
Throughout the COVID-19 hospitals and health systems have been forging new partnerships with stakeholders to ensure ongoing care for their patients, health care workers and communities.
UCLA Health is rolling out its COVID-19 vaccination program looking at clinical risk and using a social vulnerability model and, at the same time, reassuring people about the safety and effectiveness of the vaccines.
The Moderna COVID-19 vaccine continued to protect 33 healthy adults six months after receiving the second dose, according to an ongoing clinical trial examining the vaccine’s durability, published in the New England Journal of Medicine.
The AHA unveiled several new resources to aid hospitals’ and health systems’ efforts to increase the public’s confidence in COVID-19 vaccines.
All U.S. adults will become eligible for the COVID-19 vaccine by April 19, President Biden announced. That’s a couple weeks sooner than the May 1 target he announced last month.
A roundup of new resources for increasing the public’s confidence in COVID-19 vaccines.
Johnson & Johnson will soon start testing its COVID-19 vaccine candidate in U.S. adolescents, the company announced.
The Food and Drug Administration said that Moderna can add up to 50% more doses per vial of its COVID-19 vaccine. Moderna had been shipping 10-dose vials; the FDA’s change will enable shipments to contain up to 15 doses per vial.
The Department of Health and Human Services launched a nationwide network of trusted voices to encourage vaccinations and increase vaccine confidence.